BackArcus Biosciences Overview

Arcus Biosciences Current Assets

Latest current assets for RCUS: $760M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$756.00M
20.08% YoYΔ $-190.00M vs prior year quarter

Peer trimmed avg / median

Loading

Arcus Biosciences Current Assets History

Loading

Arcus Biosciences vs. peers: Current Assets Comparison

Loading

Arcus Biosciences Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arcus Biosciences (RCUS) FAQ

As of the most recent data (June 2026), RCUS shows a current assets of $760M. That compares with $950M in the prior-year period — down 20.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RCUS's current assets is now $760M (was $950M) — a 20.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Arcus Biosciences is outperforming or lagging.

Tracking RCUS's current assets over time shows whether Arcus Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $760M That compares with $950M in the prior-year period — down 20.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Arcus Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $760M) with ownership activity and broader fundamentals.

Arcus Biosciences's current assets is $760M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.